Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative low-dose dexmedetomidine nasal spray in elderly patients undergoing thoracoscopic radical lung cancer surgery under ERAS
ChiCTR2400090593Phase 4Not yet recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in sleep disorder (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: Anxiety, depression, and sleep scores. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2400090593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090593.